Meyka Pro banner
Illumina, Inc.

Illumina, Inc. (ILMN) Stock Overview

Explore Illumina, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ILMN●NASDAQ
HealthcareMedical - Diagnostics & Research
$272.00
$0.10(0.04%)
U.S. Market opens in 7h 34m

Illumina, Inc. (ILMN)

Meyka AI Score

Z

Key Financials

Market Cap41.2B
P/E Ratio50.40
EPS (TTM)$5.03
ROE0.31%
Fundamental Analysis

AI Price Forecasts

1 Month$235.08
3 Months$201.19
1 Year Target$82.00

ILMN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Illumina, Inc. (NASDAQ: ILMN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Illumina, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ILMN on the NASDAQ shows an RSI of 74.33, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $82.00 for the NASDAQ listing.

Key metrics behind Illumina, Inc.'s NASDAQ-traded stock include a P/E ratio of 50.40 and a market capitalization of 41.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ILMN on the NASDAQ.

Price Performance (NASDAQ: ILMN)

1-Day Change
0.04%
5-Day Change
7.18%
1-Month Change
26.17%
3-Month Change
50.19%
6-Month Change
131.15%
Year-to-Date (YTD) Change
107.38%
1-Year Change
196.07%
3-Year Change
103.88%
5-Year Change
-32.00%
All-Time (Max) Change
1329.32%

Contact Information

858 202 4500
5200 Illumina Way, San Diego, CA, 92122

Company Facts

86,000 Employees
IPO DateJul 28, 2000
CountryUS
Actively Trading

Frequently Asked Questions